Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population

Abstract Objective : Green tea has been found to possess anti-inflammatory, anti-oxidative and anti-carcinogenic properties. The present study examines the association between green tea drinking and hepatocellular carcinoma (HCC) and its interactions with other risk or protective factors and single...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology 2011-08, Vol.35 (4), p.362-368
Hauptverfasser: Li, Yanli, Chang, Shen-Chih, Goldstein, Binh Y, Scheider, William L, Cai, Lin, You, Nai-Chieh Y, Tarleton, Heather P, Ding, Baoguo, Zhao, Jinkou, Wu, Ming, Jiang, Qingwu, Yu, Shunzhang, Rao, Jianyu, Lu, Qing-Yi, Zhang, Zuo-Feng, Mu, Lina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 368
container_issue 4
container_start_page 362
container_title Cancer epidemiology
container_volume 35
creator Li, Yanli
Chang, Shen-Chih
Goldstein, Binh Y
Scheider, William L
Cai, Lin
You, Nai-Chieh Y
Tarleton, Heather P
Ding, Baoguo
Zhao, Jinkou
Wu, Ming
Jiang, Qingwu
Yu, Shunzhang
Rao, Jianyu
Lu, Qing-Yi
Zhang, Zuo-Feng
Mu, Lina
description Abstract Objective : Green tea has been found to possess anti-inflammatory, anti-oxidative and anti-carcinogenic properties. The present study examines the association between green tea drinking and hepatocellular carcinoma (HCC) and its interactions with other risk or protective factors and single nucleotide polymorphisms (SNP) of inflammation and oxidative stress related genes. Methods : A population-based case-control study with 204 primary HCC cases and 415 healthy controls was conducted in Taixing, China. Epidemiological data were collected using a standard questionnaire. SNPs of genes of the inflammation and metabolic pathways were genotyped at the UCLA Molecular Epidemiology Laboratory. Logistic regression was performed to estimate adjusted odds ratios and 95% confidence intervals. Results : Longer duration and larger quantities of green tea consumption were inversely associated with primary HCC. Individuals who drank green tea longer than 30 years were at lowest risk (adjusted OR = 0.44, 95% CI: 0.19–0.96) compared with non-drinkers. A strong interaction was observed between green tea drinking and alcohol consumption (adjusted OR for interaction = 3.40, 95% CI: 1.26–9.16). Green tea drinking was also observed to have a potential effect modification on HBV/HCV infection, smoking and polymorphisms of inflammation related cytokines, especially for IL-10. Conclusion : Green tea consumption may protect against development of primary HCC. Potential effect modifications of green tea on associations between primary HCC and alcohol drinking, HBV/HCV infection, and inflammation-related SNPs were suggested.
doi_str_mv 10.1016/j.canep.2011.01.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3396119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1877782111000063</els_id><sourcerecordid>2730570841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c639t-4446ef434648967c8fda35be719de367e79a8fafb96873b9f516018cf53dadf53</originalsourceid><addsrcrecordid>eNqFUt9rFDEQXsRia_UvECTggy_emWw2vx4slMPWQsEHFXwLuezEy3U3WZPdQv97s73zWvtiGPKD-ebLfDNTVW8IXhJM-Mft0poAw7LGhCxxMcyeVSdECrEQkv58frjX5Lh6mfMWY84JYS-q45pQwrhQJ1V3mQACGsEgG0Oe-mH0MXxAPrjO9L2ZX8iEFo0bQMnnGxQdGpLvTbpDGxjMGC103dSZhKxJ1ofYmxKNDFptfIAMaIhDcc9Er6ojZ7oMr_fnafXj4vP31ZfF9dfLq9X59cJyqsZF0zQcXEMb3kjFhZWuNZStQRDVAuUChDLSGbdWXAq6Vo4Rjom0jtHWtGU_rc52vMO07qG1EMZkOr1PW0fj9b-e4Df6V7zVlKpSIVUI3u8JUvw9QR517_OssxQ8TllLyTATmOOCfPcEuY1TCkWdJpjWTEnOmoKiO5RNMecE7pALwXpupt7q-2bquZkaF8OzjLePZRxi_navAD7tAFCKeesh6Ww9BAutT2BH3Ub_nw_OnsTbzgdvTXcDd5AflOhca6y_zfM0jxMhuCxO6R9dT8hX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1032598654</pqid></control><display><type>article</type><title>Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Li, Yanli ; Chang, Shen-Chih ; Goldstein, Binh Y ; Scheider, William L ; Cai, Lin ; You, Nai-Chieh Y ; Tarleton, Heather P ; Ding, Baoguo ; Zhao, Jinkou ; Wu, Ming ; Jiang, Qingwu ; Yu, Shunzhang ; Rao, Jianyu ; Lu, Qing-Yi ; Zhang, Zuo-Feng ; Mu, Lina</creator><creatorcontrib>Li, Yanli ; Chang, Shen-Chih ; Goldstein, Binh Y ; Scheider, William L ; Cai, Lin ; You, Nai-Chieh Y ; Tarleton, Heather P ; Ding, Baoguo ; Zhao, Jinkou ; Wu, Ming ; Jiang, Qingwu ; Yu, Shunzhang ; Rao, Jianyu ; Lu, Qing-Yi ; Zhang, Zuo-Feng ; Mu, Lina</creatorcontrib><description>Abstract Objective : Green tea has been found to possess anti-inflammatory, anti-oxidative and anti-carcinogenic properties. The present study examines the association between green tea drinking and hepatocellular carcinoma (HCC) and its interactions with other risk or protective factors and single nucleotide polymorphisms (SNP) of inflammation and oxidative stress related genes. Methods : A population-based case-control study with 204 primary HCC cases and 415 healthy controls was conducted in Taixing, China. Epidemiological data were collected using a standard questionnaire. SNPs of genes of the inflammation and metabolic pathways were genotyped at the UCLA Molecular Epidemiology Laboratory. Logistic regression was performed to estimate adjusted odds ratios and 95% confidence intervals. Results : Longer duration and larger quantities of green tea consumption were inversely associated with primary HCC. Individuals who drank green tea longer than 30 years were at lowest risk (adjusted OR = 0.44, 95% CI: 0.19–0.96) compared with non-drinkers. A strong interaction was observed between green tea drinking and alcohol consumption (adjusted OR for interaction = 3.40, 95% CI: 1.26–9.16). Green tea drinking was also observed to have a potential effect modification on HBV/HCV infection, smoking and polymorphisms of inflammation related cytokines, especially for IL-10. Conclusion : Green tea consumption may protect against development of primary HCC. Potential effect modifications of green tea on associations between primary HCC and alcohol drinking, HBV/HCV infection, and inflammation-related SNPs were suggested.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2011.01.005</identifier><identifier>PMID: 21315679</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Aged ; Alcohol ; Bias ; Cancer ; Carcinoma, Hepatocellular - epidemiology ; Carcinoma, Hepatocellular - genetics ; Case-Control Studies ; China - epidemiology ; Consumption ; Cytokines ; Epidemiology ; Fatalities ; Female ; Gender ; Gene expression ; Green tea ; Health sciences ; Hematology, Oncology and Palliative Medicine ; Hepatitis B virus ; Hepatitis C virus ; Humans ; Inflammation ; Inflammation - epidemiology ; Inflammation - genetics ; Internal Medicine ; Liver cancer ; Liver Neoplasms - epidemiology ; Liver Neoplasms - genetics ; Male ; Middle Aged ; Multivariate analysis ; Polymorphism, Single Nucleotide ; Polyphenols ; Primary hepatocellular carcinoma ; Risk Factors ; Tea ; Young Adult</subject><ispartof>Cancer epidemiology, 2011-08, Vol.35 (4), p.362-368</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>2011 Elsevier Ltd. All rights reserved. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c639t-4446ef434648967c8fda35be719de367e79a8fafb96873b9f516018cf53dadf53</citedby><cites>FETCH-LOGICAL-c639t-4446ef434648967c8fda35be719de367e79a8fafb96873b9f516018cf53dadf53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1032598654?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21315679$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Yanli</creatorcontrib><creatorcontrib>Chang, Shen-Chih</creatorcontrib><creatorcontrib>Goldstein, Binh Y</creatorcontrib><creatorcontrib>Scheider, William L</creatorcontrib><creatorcontrib>Cai, Lin</creatorcontrib><creatorcontrib>You, Nai-Chieh Y</creatorcontrib><creatorcontrib>Tarleton, Heather P</creatorcontrib><creatorcontrib>Ding, Baoguo</creatorcontrib><creatorcontrib>Zhao, Jinkou</creatorcontrib><creatorcontrib>Wu, Ming</creatorcontrib><creatorcontrib>Jiang, Qingwu</creatorcontrib><creatorcontrib>Yu, Shunzhang</creatorcontrib><creatorcontrib>Rao, Jianyu</creatorcontrib><creatorcontrib>Lu, Qing-Yi</creatorcontrib><creatorcontrib>Zhang, Zuo-Feng</creatorcontrib><creatorcontrib>Mu, Lina</creatorcontrib><title>Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>Abstract Objective : Green tea has been found to possess anti-inflammatory, anti-oxidative and anti-carcinogenic properties. The present study examines the association between green tea drinking and hepatocellular carcinoma (HCC) and its interactions with other risk or protective factors and single nucleotide polymorphisms (SNP) of inflammation and oxidative stress related genes. Methods : A population-based case-control study with 204 primary HCC cases and 415 healthy controls was conducted in Taixing, China. Epidemiological data were collected using a standard questionnaire. SNPs of genes of the inflammation and metabolic pathways were genotyped at the UCLA Molecular Epidemiology Laboratory. Logistic regression was performed to estimate adjusted odds ratios and 95% confidence intervals. Results : Longer duration and larger quantities of green tea consumption were inversely associated with primary HCC. Individuals who drank green tea longer than 30 years were at lowest risk (adjusted OR = 0.44, 95% CI: 0.19–0.96) compared with non-drinkers. A strong interaction was observed between green tea drinking and alcohol consumption (adjusted OR for interaction = 3.40, 95% CI: 1.26–9.16). Green tea drinking was also observed to have a potential effect modification on HBV/HCV infection, smoking and polymorphisms of inflammation related cytokines, especially for IL-10. Conclusion : Green tea consumption may protect against development of primary HCC. Potential effect modifications of green tea on associations between primary HCC and alcohol drinking, HBV/HCV infection, and inflammation-related SNPs were suggested.</description><subject>Adult</subject><subject>Aged</subject><subject>Alcohol</subject><subject>Bias</subject><subject>Cancer</subject><subject>Carcinoma, Hepatocellular - epidemiology</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Case-Control Studies</subject><subject>China - epidemiology</subject><subject>Consumption</subject><subject>Cytokines</subject><subject>Epidemiology</subject><subject>Fatalities</subject><subject>Female</subject><subject>Gender</subject><subject>Gene expression</subject><subject>Green tea</subject><subject>Health sciences</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hepatitis B virus</subject><subject>Hepatitis C virus</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammation - epidemiology</subject><subject>Inflammation - genetics</subject><subject>Internal Medicine</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - epidemiology</subject><subject>Liver Neoplasms - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Polyphenols</subject><subject>Primary hepatocellular carcinoma</subject><subject>Risk Factors</subject><subject>Tea</subject><subject>Young Adult</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUt9rFDEQXsRia_UvECTggy_emWw2vx4slMPWQsEHFXwLuezEy3U3WZPdQv97s73zWvtiGPKD-ebLfDNTVW8IXhJM-Mft0poAw7LGhCxxMcyeVSdECrEQkv58frjX5Lh6mfMWY84JYS-q45pQwrhQJ1V3mQACGsEgG0Oe-mH0MXxAPrjO9L2ZX8iEFo0bQMnnGxQdGpLvTbpDGxjMGC103dSZhKxJ1ofYmxKNDFptfIAMaIhDcc9Er6ojZ7oMr_fnafXj4vP31ZfF9dfLq9X59cJyqsZF0zQcXEMb3kjFhZWuNZStQRDVAuUChDLSGbdWXAq6Vo4Rjom0jtHWtGU_rc52vMO07qG1EMZkOr1PW0fj9b-e4Df6V7zVlKpSIVUI3u8JUvw9QR517_OssxQ8TllLyTATmOOCfPcEuY1TCkWdJpjWTEnOmoKiO5RNMecE7pALwXpupt7q-2bquZkaF8OzjLePZRxi_navAD7tAFCKeesh6Ww9BAutT2BH3Ub_nw_OnsTbzgdvTXcDd5AflOhca6y_zfM0jxMhuCxO6R9dT8hX</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Li, Yanli</creator><creator>Chang, Shen-Chih</creator><creator>Goldstein, Binh Y</creator><creator>Scheider, William L</creator><creator>Cai, Lin</creator><creator>You, Nai-Chieh Y</creator><creator>Tarleton, Heather P</creator><creator>Ding, Baoguo</creator><creator>Zhao, Jinkou</creator><creator>Wu, Ming</creator><creator>Jiang, Qingwu</creator><creator>Yu, Shunzhang</creator><creator>Rao, Jianyu</creator><creator>Lu, Qing-Yi</creator><creator>Zhang, Zuo-Feng</creator><creator>Mu, Lina</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20110801</creationdate><title>Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population</title><author>Li, Yanli ; Chang, Shen-Chih ; Goldstein, Binh Y ; Scheider, William L ; Cai, Lin ; You, Nai-Chieh Y ; Tarleton, Heather P ; Ding, Baoguo ; Zhao, Jinkou ; Wu, Ming ; Jiang, Qingwu ; Yu, Shunzhang ; Rao, Jianyu ; Lu, Qing-Yi ; Zhang, Zuo-Feng ; Mu, Lina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c639t-4446ef434648967c8fda35be719de367e79a8fafb96873b9f516018cf53dadf53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Alcohol</topic><topic>Bias</topic><topic>Cancer</topic><topic>Carcinoma, Hepatocellular - epidemiology</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Case-Control Studies</topic><topic>China - epidemiology</topic><topic>Consumption</topic><topic>Cytokines</topic><topic>Epidemiology</topic><topic>Fatalities</topic><topic>Female</topic><topic>Gender</topic><topic>Gene expression</topic><topic>Green tea</topic><topic>Health sciences</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hepatitis B virus</topic><topic>Hepatitis C virus</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammation - epidemiology</topic><topic>Inflammation - genetics</topic><topic>Internal Medicine</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - epidemiology</topic><topic>Liver Neoplasms - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Polyphenols</topic><topic>Primary hepatocellular carcinoma</topic><topic>Risk Factors</topic><topic>Tea</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Yanli</creatorcontrib><creatorcontrib>Chang, Shen-Chih</creatorcontrib><creatorcontrib>Goldstein, Binh Y</creatorcontrib><creatorcontrib>Scheider, William L</creatorcontrib><creatorcontrib>Cai, Lin</creatorcontrib><creatorcontrib>You, Nai-Chieh Y</creatorcontrib><creatorcontrib>Tarleton, Heather P</creatorcontrib><creatorcontrib>Ding, Baoguo</creatorcontrib><creatorcontrib>Zhao, Jinkou</creatorcontrib><creatorcontrib>Wu, Ming</creatorcontrib><creatorcontrib>Jiang, Qingwu</creatorcontrib><creatorcontrib>Yu, Shunzhang</creatorcontrib><creatorcontrib>Rao, Jianyu</creatorcontrib><creatorcontrib>Lu, Qing-Yi</creatorcontrib><creatorcontrib>Zhang, Zuo-Feng</creatorcontrib><creatorcontrib>Mu, Lina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yanli</au><au>Chang, Shen-Chih</au><au>Goldstein, Binh Y</au><au>Scheider, William L</au><au>Cai, Lin</au><au>You, Nai-Chieh Y</au><au>Tarleton, Heather P</au><au>Ding, Baoguo</au><au>Zhao, Jinkou</au><au>Wu, Ming</au><au>Jiang, Qingwu</au><au>Yu, Shunzhang</au><au>Rao, Jianyu</au><au>Lu, Qing-Yi</au><au>Zhang, Zuo-Feng</au><au>Mu, Lina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>35</volume><issue>4</issue><spage>362</spage><epage>368</epage><pages>362-368</pages><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>Abstract Objective : Green tea has been found to possess anti-inflammatory, anti-oxidative and anti-carcinogenic properties. The present study examines the association between green tea drinking and hepatocellular carcinoma (HCC) and its interactions with other risk or protective factors and single nucleotide polymorphisms (SNP) of inflammation and oxidative stress related genes. Methods : A population-based case-control study with 204 primary HCC cases and 415 healthy controls was conducted in Taixing, China. Epidemiological data were collected using a standard questionnaire. SNPs of genes of the inflammation and metabolic pathways were genotyped at the UCLA Molecular Epidemiology Laboratory. Logistic regression was performed to estimate adjusted odds ratios and 95% confidence intervals. Results : Longer duration and larger quantities of green tea consumption were inversely associated with primary HCC. Individuals who drank green tea longer than 30 years were at lowest risk (adjusted OR = 0.44, 95% CI: 0.19–0.96) compared with non-drinkers. A strong interaction was observed between green tea drinking and alcohol consumption (adjusted OR for interaction = 3.40, 95% CI: 1.26–9.16). Green tea drinking was also observed to have a potential effect modification on HBV/HCV infection, smoking and polymorphisms of inflammation related cytokines, especially for IL-10. Conclusion : Green tea consumption may protect against development of primary HCC. Potential effect modifications of green tea on associations between primary HCC and alcohol drinking, HBV/HCV infection, and inflammation-related SNPs were suggested.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>21315679</pmid><doi>10.1016/j.canep.2011.01.005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1877-7821
ispartof Cancer epidemiology, 2011-08, Vol.35 (4), p.362-368
issn 1877-7821
1877-783X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3396119
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Aged
Alcohol
Bias
Cancer
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - genetics
Case-Control Studies
China - epidemiology
Consumption
Cytokines
Epidemiology
Fatalities
Female
Gender
Gene expression
Green tea
Health sciences
Hematology, Oncology and Palliative Medicine
Hepatitis B virus
Hepatitis C virus
Humans
Inflammation
Inflammation - epidemiology
Inflammation - genetics
Internal Medicine
Liver cancer
Liver Neoplasms - epidemiology
Liver Neoplasms - genetics
Male
Middle Aged
Multivariate analysis
Polymorphism, Single Nucleotide
Polyphenols
Primary hepatocellular carcinoma
Risk Factors
Tea
Young Adult
title Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A50%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Green%20tea%20consumption,%20inflammation%20and%20the%20risk%20of%20primary%20hepatocellular%20carcinoma%20in%20a%20Chinese%20population&rft.jtitle=Cancer%20epidemiology&rft.au=Li,%20Yanli&rft.date=2011-08-01&rft.volume=35&rft.issue=4&rft.spage=362&rft.epage=368&rft.pages=362-368&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2011.01.005&rft_dat=%3Cproquest_pubme%3E2730570841%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1032598654&rft_id=info:pmid/21315679&rft_els_id=1_s2_0_S1877782111000063&rfr_iscdi=true